Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alamos Gold Announces Renewal of Normal Course Issuer Bid
-
AITX Subsidiary RAD-G Moves SARA From Proof of Concept to Paying Agentic AI Clients
-
ParaZero Successfully Completes First Live DefendAir Demonstration in Europe for Senior NATO Officers from Multiple Western European Countries
-
IEEE SA Emerging Technology Award Recognizes Standards Working Group Founded and Co-Led by Waterfall Network Researchers on Recurring Payments on DLTs
-
FLINT Secures $451 million in New Contract Awards and Renewals
-
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
-
KULR Technology Group Announces Six-Month Pause on At-the-Market Equity Offering Program
-
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
EdgeMode Secure Strategic Power Milestone for Europe’s Largest AI Data Center Pipeline
-
Aether Holdings Advances Growth Strategy with Purchase of Manhattan Office
-
Vivos Inc Summarzes Preogress in its Animal Therapy Division
-
Vivakor Signs Letter of Intent to Acquire Coyote Oilfield Services, Expanding Integrated Midstream Capabilities
-
Digital Brands Group Advances Suite of AI-Powered Tools for Global Brand Protection and Growth
-
TechForce Robotics Unveils Proprietary Beverage Robotics Platform Designed to Increase Revenue and Maximize High-Volume Venue Throughput
-
La Rosa Holdings Corp. Reports 31% Annualized Rate Reduction in Technology Costs in 2025 compared to 2022 Through Proprietary Platform Strategy
-
Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program
-
Imviva Biotech Announces First Patient Dosed in Phase 1b/2 TENACITY-01 Trial of CTD402 CAR-T Cell Therapy
-
Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways
-
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
-
Fixing of Coupon Interest Rate
-
Fixing of coupon rate effective from 1 January 2026
-
Peer to Peer Network, Inc. Announces Contract With Hopscotch Air® to Deploy Tier-1 AI Communications Suite
-
Cohen & Company Announces Special Cash Dividend of $2.00 Per Share
-
Cohen & Company Announces Special Cash Dividend of $2.00 Per Share
-
Acres.com Supports Park Street Homes’ National Expansion of Urban, Attainable Housing
-
Adeia Raises 2025 Financial Outlook
-
Baker Hughes to Supply Liquefaction Equipment for Commonwealth LNG Export Project
-
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA
-
Adeia and Disney Enter Into Long-Term Media IP License Agreement
-
Tree Island Announces Appointment of Guy Elliott to Board of Directors
-
CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O’Malley Jr. to its Board of Directors
-
ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
-
Changes to Index Tracked by Sprott Junior Gold Miners ETF (SGDJ)
-
Ascendiant Capital Markets: “Society Pass Inc (Nasdaq: SOPA) stock is undervalued and should be higher on NusaTrip valuation”
-
Par Pacific Announces 2026 Capital Expenditure Guidance
-
Clockwise Announces Yearly Distributions on $TIME
-
Entrée Resources Provides Update on Entrée/Oyu Tolgoi Joint Venture License Matters
-
Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair
-
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
-
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer
-
Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
-
RESTEM to Present Company Overview in Biotech Showcase 2026
-
Kahuna Labs Names Customer Support Visionary Judith Platz as Field Chief Customer Officer to Help Redefine the Future of Enterprise Support with AI
-
EagleNXT Appoints Falcon UAV as Master Distributor for Asia Pacific Region
-
Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
-
New Crypto Mutuum Finance (MUTM) Reports 250% Token Growth as Phase 6 Nears 100% with Over $19M Raised
-
Sinaptica Therapeutics Completes Scientific Advisory Board, Bringing Together Leading Voices Across Patients, Science, Medicine, and Commercial Strategy
-
Leading Quantum Scientists Join Zapata’s Scientific Advisory Board, Validating Its Software-First Approach
-
Immutep Announces Positive Update on IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases, from Phase I Study
